Treatment of sepsis in the neonate

Journal of Intravenous Nursing

Volumn 21, Issue 5, 1998, Pages 275-281

  Sater, Kathy J ^a,b,c  

^a Shriners Hospital for Children   (United States)

^b WICHITA STATE UNIVERSITY   (United States)

^c Memorial Hermann Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; GENTAMICIN; IMMUNOGLOBULIN;

BACTERIAL INFECTION; CLINICAL FEATURE; FAMILY; FEVER; HEALTH CARE COST; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; NEWBORN SEPSIS; PSYCHOSOCIAL ENVIRONMENT; REIMBURSEMENT; REVIEW; RISK FACTOR; TREATMENT PLANNING;

DECISION TREES; HUMANS; INFANT, NEWBORN; NEONATAL NURSING; NURSING ASSESSMENT; PATIENT SELECTION; RISK FACTORS; SEPSIS;

EID: 0031693591     PISSN: 08965846     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Wedgwood JF, Palmer R, Weinberger B. Development of the ability to make IgG and IgA in Newborns and Infants. Mt Sinai J Med 1994;61:409-15.
2. Powell KR. Evaluation and management of febrile infants younger than 60 days of age. Pediatr Infect Dis J 1990;9:153-7.
3. Committee on Infectious Diseases and Committee on Fetus and Newborn. 1992 Guideline for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics 1992;90: 775-8.
4. American College of Obstetricians and Gynecologists. Group B streptococcal infection in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 1992.
5. Peralta-Carcelen M, Fargason CA, Cliver SP, et al. Impact of maternal Group B streptococcal screening on pediatric management in full-term newborns. Arch Pediatr Adolesc Med 1995;150:802-8.
6. Oujevolk AV, Fiore DC. Neonatal group B Streptococcus infection: recommendations for screening and prophylaxis. West J Med 1995;163:68-9.
7. Yancey MK, Duff P, Kubilis P, Clark P, Frentzen. Risk factors for neonatal sepsis. Obstet Gynecol 1996;87:188-94.
8. Saez-Llorens X, Ah-Chu MS, Castano E, et al. Intrapartum prophylaxis with ceftriaxone decreases rates of bacterial colonization and early-onset infection in newborns. Clin Infect Dis 1995;21:876-80.
9. Weisman LE, Stoll BJ, Kueser TJ, et al. Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates. J Pediatr 1994;125:922-30.
10. Thompsen AC, Morup CL, Hansen KB. Antibiotic elimination of group B streptococci in the urine prevention of preterm labor. Lancet 1987;1:591-3.
11. Boyer KM, Gadzala CA, Kelly PD, et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal culture. J Infect Dis 1983;148: 802-9.
12. Nyhan WI, Fousek MD. Septicemia of the newborn. Pediatrics 1958;22:268-78.
13. Gluck L, Wood HF, Fousek MD. Septicemia in the newborn. Pediatr Clin North Am 1966;13:1131-48.
14. Moorman RS Jr, Sell SH. Neonatal septicemia. South Med J 1961;54:137-41.
15. Buetow KC, Klein SW, Lane RB. Septicemia in premature infants. Am J Dis Child 1965;110:29-41.
16. Whaley LF, Wong DL. Nursing care of infants and children. St. Louis: Mosby, 1991.
17. Suspected neonatal sepsis critical pathway. Stanford, CA: Neonatology Division, Lucile Packard Children's Hospital, 1994.
18. Baraff LJ, Bass JW, Fleischer GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Ann Emerg Med 1993;22:1198-210.
19. McIntrye P, Isaacs D. Lumbar puncture in suspected neonatal sepsis. J Paediatric Child Health 1995;31:1-2.
20. Quinn KJ, Maguire C, Stavola JJ, et al. The natural history of the infant hospitalized suspected of having sepsis. New York: Division of Pediatric Infectious Diseases, The N.Y. Hospital-Cornell Medical Center, 1997.
21. Manroe BI, Weinberg AG, Rosenfeld CR, et al. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979;95:89-98.
22. Bramson RT, Meyer TL, Silbiger ML, et al. The futility of the chest radiograph in the febrile infant without respiratory symptoms. Pediatrics 1993;92:524-6.
23. American Academy of Pediatrics. Red book. Evanston, IL: 1994;440-1.
24. Hurst MK, Yoder BA. Detection of bacteremia in young infants: is 48 hours adequate? Pediatr Res 1995;37:292A.
25. Remington JS, Klein JO (eds.). Infectious diseases of the fetus and newborn infant. In: Group B streptococcal infection, 3rd ed. Philadelphia: WB Saunders; 1990, 786.
26. Young TE, Mangum OB. Neofax: a manual of drugs used in neonatal care. Columbus, OH: Ross Laboratories, 1995.
27. Wong DL, Perry SE. Maternal child nursing care. St Louis: Mosby, 1998.
28. Schulte EB, Price DL, James SR. Thompson's pediatric nursing. Philadelphia: WB Saunders, 1997.
29. Terry J, Baranoski L, Lonsway RA, Hedrick C. Intravenous therapy: clinical principles and practice. Philadelphia: WB Saunders, 1995.
30. Weinstein SM, Plumer's principles & practice of intravenous therapy. Philadelphia: Lippincott-Raven, 1997.
31. Miller J, Sater KJ, Mazur L. Impact of a clinical pathway in the care of febrile infants. Ambulatory Child Health 1996;2:123-7.